MRK - Company ID 0000310158
The table below shows Merck & Co., Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Revenue | $18.09B | $16.61B | $16.29B | $17.28B | $15.81B | $15.53B |
| Cost of revenue | $4.89B | $4.39B | $4.20B | $3.85B | $3.56B | $3.42B |
| Gross profit | - | - | - | - | - | - |
| R&D | $4.54B | $9.74B | $12.59B | $4.23B | $4.05B | $3.62B |
Merck & Co., Inc. reported annual revenue of $65.01B for fiscal year 2025. That is up 1.3% from $64.17B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $39.81B (FY 2016) to $65.01B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $2.89B |
| $2.90B |
| $2.70B |
| $2.63B |
| $2.65B |
| $2.55B |
| Operating income | - | - | - | - | - | - |
| Income tax | $492.00M | $654.00M | $709.00M | $958.00M | $571.00M | $818.00M |
| Net income | $5.07B | -$1.33B | -$4.24B | $5.79B | $4.43B | $5.08B |
| EPS (diluted) | $2.04 | -$0.54 | -$1.72 | $2.32 | $1.76 | $2.01 |